Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator: primary results of the REMOTE-CIED randomized trial.

Versteeg H, Timmermans I, Widdershoven J, Kimman GJ, Prevot S, Rauwolf T, Scholten MF, Zitron E, Mabo P, Denollet J, Pedersen SS, Meine M.

Europace. 2019 Jun 5. pii: euz140. doi: 10.1093/europace/euz140. [Epub ahead of print]

PMID:
31168604
2.

Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.

Blom LJ, Visser M, Christiaans I, Scholten MF, Bootsma M, van den Berg MP, Yap SC, van der Heijden JF, Doevendans PA, Loh P, Postema PG, Barge-Schaapsveld DQ, Hofman N, Volders PGA, Wilde AA, Hassink RJ.

Europace. 2019 May 21. pii: euz151. doi: 10.1093/europace/euz151. [Epub ahead of print]

PMID:
31114860
3.

Shorter cryoballoon applications times do effect efficacy but result in less phrenic nerve injury: Results of the randomized 123 study.

Molenaar MMD, Timmermans CC, Hesselink T, Scholten MF, Ter Bekke RMA, Luermans JGLM, Brusse-Keizer M, Kraaier K, Ten Haken B, Grandjean JG, Vernooy K, van Opstal JM.

Pacing Clin Electrophysiol. 2019 May;42(5):508-514. doi: 10.1111/pace.13626. Epub 2019 Mar 5.

PMID:
30756393
4.

Erratum to: Use of three-dimensional computed tomography overlay for real-time cryoballoon ablation in atrial fibrillation reduces radiation dose and contrast dye.

Oude Velthuis B, Molenaar MMD, Reinhart Dorman HG, Stevenhagen JY, Scholten MF, van der Palen J, van Opstal JM.

Neth Heart J. 2017 Jul;25(7-8):467-468. doi: 10.1007/s12471-017-1013-0. No abstract available.

5.

Use of three-dimensional computed tomography overlay for real-time cryoballoon ablation in atrial fibrillation reduces radiation dose and contrast dye.

Oude Velthuis B, Molenaar M, Reinhart Dorman HG, Stevenhagen JY, Scholten MF, van der Palen J, van Opstal JM.

Neth Heart J. 2017 Jun;25(6):388-393. doi: 10.1007/s12471-017-0962-7. Erratum in: Neth Heart J. 2017 Jun 19;:.

6.

Long-term results of surgical minimally invasive pulmonary vein isolation for paroxysmal lone atrial fibrillation.

De Maat GE, Pozzoli A, Scholten MF, Van Gelder IC, Blaauw Y, Mulder BA, Della Bella P, Alfieri OR, Benussi S, Mariani MA.

Europace. 2015 May;17(5):747-52. doi: 10.1093/europace/euu287. Epub 2015 Jan 18.

PMID:
25600767
7.

Diagnostic yield of external loop recording in patients with acute ischemic stroke or TIA.

Plas GJ, Bos J, Velthuis BO, Scholten MF, den Hertog HM, Brouwers PJ.

J Neurol. 2015 Mar;262(3):682-8. doi: 10.1007/s00415-014-7621-3. Epub 2015 Jan 4.

PMID:
25557280
8.

Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS).

Kraaier K, Olimulder MA, van Dessel PF, Wilde AA, Scholten MF.

Neth Heart J. 2014 Oct;22(10):440-5. doi: 10.1007/s12471-014-0583-3.

9.

Author reply: To PMID 23913594.

Dorman HG, Scholten MF, Stevenhagen J, Van Opstal JM.

Europace. 2015 Jan;17(1):166-7. doi: 10.1093/europace/euu199. Epub 2014 Aug 8. No abstract available.

PMID:
25107944
10.

Scar tissue and microvolt T-wave alternans.

Kraaier K, Olimulder MA, Galjee MA, van Dessel PF, van der Palen J, Wilde AA, Scholten MF.

Int J Cardiovasc Imaging. 2014 Apr;30(4):773-9. doi: 10.1007/s10554-014-0389-9. Epub 2014 Feb 23.

PMID:
24563008
11.

Surgical minimally invasive pulmonary vein isolation for lone atrial fibrillation: midterm results of a multicenter study.

De Maat GE, Pozzoli A, Scholten MF, Hillege HL, Van Gelder IC, Alfieri OR, Benussi S, Mariani MA.

Innovations (Phila). 2013 Nov-Dec;8(6):410-5. doi: 10.1097/IMI.0000000000000029.

PMID:
24356430
12.

Performance of an external transtelephonic loop recorder for automated detection of paroxysmal atrial fibrillation.

Velthuis BO, Bos J, Kraaier K, Stevenhagen J, van Opstal JM, van der Palen J, Scholten MF.

Ann Noninvasive Electrocardiol. 2013 Nov;18(6):564-70. doi: 10.1111/anec.12075. Epub 2013 Sep 9.

PMID:
24303971
13.

Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score.

Kraaier K, Scholten MF, Tijssen JG, Theuns DA, Jordaens LJ, Wilde AA, van Dessel PF.

Europace. 2014 Jan;16(1):40-6. doi: 10.1093/europace/eut223. Epub 2013 Aug 4.

PMID:
23918791
14.

High failure rate of the 5 French Sorin Hepta 4B pacemaker lead.

Reinhart Dorman HG, Van Opstal JM, Stevenhagen J, Scholten MF.

Europace. 2014 Jan;16(1):88-91. doi: 10.1093/europace/eut245. Epub 2013 Aug 2.

PMID:
23913594
15.

Optimisation of cardiac resynchronization therapy in clinical practice during exercise.

Molenaar MM, Oude Velthuis B, Scholten MF, Stevenhagen JY, Wesselink WA, van Opstal JM.

Neth Heart J. 2013 Oct;21(10):458-63. doi: 10.1007/s12471-013-0438-3.

16.

Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients.

Kraaier K, Starrenburg AH, Verheggen RM, van der Palen J, Scholten MF.

Neth Heart J. 2013 Apr;21(4):191-5. doi: 10.1007/s12471-012-0345-z.

17.

Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging.

Olimulder MA, Kraaier K, Galjee MA, Scholten MF, van Es J, Wagenaar LJ, van der Palen J, von Birgelen C.

Int J Cardiovasc Imaging. 2013 Jan;29(1):169-76. doi: 10.1007/s10554-012-0077-6. Epub 2012 Jun 9.

18.

Conductor externalization of the Riata internal cardioverter defibrillator lead: tip of the iceberg? Report of three cases and review of literature.

Dorman HG, van Opstal JM, Stevenhagen J, Scholten MF.

Europace. 2012 Aug;14(8):1161-4. doi: 10.1093/europace/eus064. Epub 2012 Mar 19. Review.

PMID:
22431444
19.

Feasibility of TWA testing - reply.

Kraaier K, Scholten MF.

Neth Heart J. 2012 May;20(5):248. doi: 10.1007/s12471-012-0265-y. No abstract available.

20.

Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation.

Oude Velthuis B, Stevenhagen J, van Opstal JM, Scholten MF.

Neth Heart J. 2012 Jan;20(1):12-5. doi: 10.1007/s12471-011-0223-0.

21.

Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators?

Kraaier K, McCracken T, van der Palen J, Wilde AA, Scholten MF.

Neth Heart J. 2011 Jan;19(1):6-9. doi: 10.1007/s12471-010-0053-5.

22.

Concomitant off-pump modified maze and coronary surgery.

Mariani MA, Stoker T, Scholten MF, Addis A, Corradi D, Alfieri O, Benussi S.

Ann Thorac Surg. 2011 Jun;91(6):e96-8. doi: 10.1016/j.athoracsur.2011.01.094.

PMID:
21619960
23.

Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast-enhancement cardiovascular magnetic resonance imaging study.

Olimulder MA, Kraaier K, Galjee MA, Scholten MF, van Es J, Wagenaar LJ, van der Palen J, von Birgelen C.

Heart Vessels. 2012 May;27(3):250-7. doi: 10.1007/s00380-011-0150-4. Epub 2011 May 20.

PMID:
21598029
24.

Use of a biventricular implantable cardioverter defibrillator in a patient with a neurostimulator: is it a safe combination?

Dorman HG, Onrust A, Brants R, Stevenhagen YJ, Scholten MF.

Neth Heart J. 2015 Feb;23(2):145-6. doi: 10.1007/s12471-011-0116-2. No abstract available.

25.

ECG quantification of myocardial scar does not differ between primary and secondary prevention ICD recipients with ischemic heart disease.

Kraaier K, van Dessel PF, van der Palen J, Wilde AA, Scholten MF.

Pacing Clin Electrophysiol. 2010 Feb;33(2):192-7. doi: 10.1111/j.1540-8159.2009.02611.x. Epub 2009 Nov 4.

PMID:
19889190
26.

Microvolt T-wave alternans during exercise and pacing are not comparable.

Kraaier K, Verhorst PM, van der Palen J, van Dessel PF, Wilde AA, Scholten MF.

Europace. 2009 Oct;11(10):1375-80. doi: 10.1093/europace/eup253. Epub 2009 Sep 15.

PMID:
19758980
27.

A shock lead intentionally placed in the left ventricle.

Kraaier K, Verhorst PM, Scholten MF.

Pacing Clin Electrophysiol. 2009 May;32(5):675-6. doi: 10.1111/j.1540-8159.2009.02345.x.

PMID:
19422593
28.

Towards a better risk stratification for sudden cardiac death in patients with structural heart disease.

Kraaier K, Verhorst PM, van Dessel PF, Wilde AA, Scholten MF.

Neth Heart J. 2009 Mar;17(3):101-6.

29.

Challenging pacemaker implantation: persistent left superior vena cava with absent right superior vena cava.

Kraaier K, Poker J, von Birgelen C, Scholten MF.

Herzschrittmacherther Elektrophysiol. 2008 Dec;19(4):185-7. doi: 10.1007/s00399-008-0015-4. Epub 2009 Feb 11.

PMID:
19214419
30.

Acute success and short-term follow-up of catheter ablation of isthmus-dependent atrial flutter; a comparison of 8 mm tip radiofrequency and cryothermy catheters.

Thornton AS, Janse P, Alings M, Scholten MF, Mekel JM, Miltenburg M, Jessurun E, Jordaens L.

J Interv Card Electrophysiol. 2008 Apr;21(3):241-8. doi: 10.1007/s10840-008-9209-2. Epub 2008 Mar 25.

31.

Symptoms versus objective rhythm monitoring in patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolation.

Janse PA, van Belle YL, Theuns DA, Rivero-Ayerza M, Scholten MF, Jordaens LJ.

Eur J Cardiovasc Nurs. 2008 Jun;7(2):147-51. Epub 2007 Oct 17.

PMID:
17942370
32.

One-year follow-up in a prospective, randomized study comparing radiofrequency and cryoablation of arrhythmias in Koch's triangle: clinical symptoms and event recording.

Kimman GJ, Theuns DA, Janse PA, Rivero-Ayerza M, Scholten MF, Szili-Torok T, Jordaens LJ.

Europace. 2006 Aug;8(8):592-5. Epub 2006 Jun 27.

PMID:
16803840
33.

Imaging of a coronary artery bypass graft during coronary sinus venography.

Thornton AS, Scholten MF, Jordaens LJ.

Cardiovasc J S Afr. 2006 Mar-Apr;17(2):73-4.

34.

Targets and endpoints in ablation therapy for atrial fibrillation in the light of pathophysiological mechanisms.

Scholten MF, Thornton AS, Mekel JM, Jordaens LJ.

J Interv Card Electrophysiol. 2006 Jan;15(1):27-33. Review.

PMID:
16680547
35.

Magnetic navigation in AV nodal re-entrant tachycardia study: early results of ablation with one- and three-magnet catheters.

Thornton AS, Janse P, Theuns DA, Scholten MF, Jordaens LJ.

Europace. 2006 Apr;8(4):225-30. Epub 2006 Feb 21.

PMID:
16627445
36.

Left ventricular lead placement within a coronary sinus side branch using remote magnetic navigation of a guidewire: a feasibility study.

Rivero-Ayerza M, Thornton AS, Theuns DA, Scholten MF, Mekel JM, Res J, Jordaens LJ.

J Cardiovasc Electrophysiol. 2006 Feb;17(2):128-33.

PMID:
16533248
37.

Intracardiac echocardiography during interventional procedures.

Vaina S, Ligthart J, Vijayakumar M, Ten Cate FJ, Witsenburg M, Jordaens LJ, Sianos G, Thornton AS, Scholten MF, de Jaegere P, Serruys PW.

EuroIntervention. 2006 Feb;1(4):454-64.

PMID:
19755221
38.

Pulmonary vein antrum isolation guided by phased-array intracardiac echocardiography: A third way to do PV ablation.

Scholten MF, Thornton AS, Mekel J, Rivero-Ayerza MJ, Marrouche NF, Jordaens LJ.

Neth Heart J. 2005 Dec;13(12):439-443.

39.

Contrast echocardiography for perfusion in right ventricular cardiomyopathy.

Nemes A, Vletter WB, Scholten MF, ten Cate FJ.

Eur J Echocardiogr. 2005 Dec;6(6):470-2.

PMID:
16293534
40.

Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: differences between primary and secondary prophylaxis.

Theuns DA, Thornton AS, Klootwijk AP, Scholten MF, Vantrimpont PJ, Balk AH, Jordaens LJ.

Eur J Heart Fail. 2005 Oct;7(6):1027-32. Epub 2005 Aug 16.

41.

Anticoagulation in atrial fibrillation and flutter.

Scholten MF, Thornton AS, Mekel JM, Koudstaal PJ, Jordaens LJ.

Europace. 2005 Sep;7(5):492-9. Review.

PMID:
16087116
42.

Combined transesophageal echocardiography and transesophageal cardioversion probe: technical aspects.

Kronzon I, Tunick PA, Scholten MF, Kerber RE, Roelandt JR.

J Am Soc Echocardiogr. 2005 Mar;18(3):213-5.

PMID:
15746708
43.

Sixteen multidetector row computed tomography of pulmonary veins: 3-months' follow-up after treatment of paroxysmal atrial fibrillation with cryothermal ablation.

Maksimović R, Scholten MF, Cademartiri F, Jordaens LJ, Pattynama PM.

Eur Radiol. 2005 Jun;15(6):1122-7. Epub 2005 Feb 19.

PMID:
15723214
44.

Left ventricular lead placement within a coronary sinus side branch, using only a floppy guide wire and magnetic navigation.

Thornton AS, Alings M, Scholten MF, Jordaens LJ.

Heart. 2005 Mar;91(3):e22. No abstract available.

45.

CRAVT: a prospective, randomized study comparing transvenous cryothermal and radiofrequency ablation in atrioventricular nodal re-entrant tachycardia.

Kimman GP, Theuns DA, Szili-Torok T, Scholten MF, Res JC, Jordaens LJ.

Eur Heart J. 2004 Dec;25(24):2232-7.

PMID:
15589641
46.

Usefulness of transesophageal echocardiography using a combined probe when converting atrial fibrillation to sinus rhythm.

Scholten MF, Thornton AS, Jordaens LJ, Roelandt JR, Kerber RE, Kronzon I.

Am J Cardiol. 2004 Aug 15;94(4):470-3.

PMID:
15325931
47.

Twiddler's syndrome detected by home monitoring device.

Scholten MF, Thornton AS, Theuns DA, Res J, Jordaens LJ.

Pacing Clin Electrophysiol. 2004 Aug;27(8):1151-2.

PMID:
15305967
48.

Visualization of a coronary sinus valve using intracardiac echocardiography.

Scholten MF, Szili-Torok T, Thornton AS, Roelandt JR, Jordaens LJ.

Eur J Echocardiogr. 2004 Jan;5(1):93-6.

PMID:
15113020
49.

Catheter ablation of atrial fibrillation: still investigational or already an established therapy?

Scholten MF, Jordaens LJ.

Europace. 2004 Mar;6(2):79-82. No abstract available.

PMID:
15018863
50.

First Dutch experience with percutaneous left atrial appendage transcatheter occlusion.

Scholten MF, Jordaens LJ, Cummins PA, Serruys PW.

Neth Heart J. 2003 Dec;11(12):506-509.

Supplemental Content

Loading ...
Support Center